Biophytis to Restate Previously Issued Financial Statements
PARIS and CAMBRIDGE, Mass., Oct. 06, 2023 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS) (the “Company” or “Biophytis”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging…